Ipca Lab, Ajanta Pharma: Two pharma stocks HDFC Securities is bullish on

The level of 11,050 should be followed as a stop-loss on a closing basis in Nifty longs

algo trading
Vinay Rajani Mumbai
2 min read Last Updated : Mar 04 2020 | 8:17 AM IST
Key Nifty levels to watch today

Nifty took support exactly on the upward sloping channel on the weekly charts. The level of 11,050 should be followed as a stop-loss on a closing basis in Nifty longs. Resistance zone for Nifty is seen at 11,433-11,536.

BUY AJANTA PHARMA (1477.5): | TARGET: Rs 1,590 | STOP-LOSS: Rs 1,425

The stock price has closed at 2-year highs with rising volumes. It consolidated for a while, formed a pennant pattern on the daily chart and broke out on March 3, 2020. This is one of the best performing stocks in the pharma space in last three months. The stock is also placed above all important moving average parameters.

BUY IPCA LAB (Rs 1,506) | TARGET: Rs 1,625 | STOP-LOSS: Rs 1,450

The stock price has registered new all time high at Rs 1,529 with healthy volumes. It broke out from the consolidation zone of last two weeks. The primary trend of the stock has been bullish with higher tops and higher bottoms formation. Oscillators and Indicators have also been showing strength in the uptrend for the stock.
Disclaimer: The author is a Technical Analyst at HDFC Securities and may have positions in one or all of the above mentioned stocks. Views expressed are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Nifty Outlooktechnical analysisstocks technical analysisMarketsHDFC Securities

Next Story